跳至主要内容
临床试验/CTRI/2019/07/020248
CTRI/2019/07/020248招募中未知

A Randomized controlled trial to study the efficacy and safety of plasma exchange compared to standard medical therapy in patients with severe drug induced liver injury with or without underlying chronic liver disease.

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Grade IV DILI With T.B > 15
  • 2) DILI Manifesting as ACLF (Acute on chronic Liver failure) /ALF (Acute Liver Failure) with no transplant option

排除标准

  • 1) Evidence of active infection
  • 2) Refusal of consent or assent
  • 3) Patients with clinical suspicion of irreversible brain injury
  • 4) Pregnancy
  • 5) HCC (Hepatocellular Carcinoma) or any other malignancy
  • 6) Kidney failure
  • 7) Portal vein thrombosis
  • 8) Upper GastroIntestinal bleed
  • 9) Transplant

研究者

相似试验

Effectiveness of plasma exchange (biological) in... | 临床试验